MedTrace Logo

Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients

NCT06421285 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-06-29

No results posted yet for this study

Summary

Research purpose: Lymphedema is a very common complication in breast cancer patients. However, since there is currently no curable treatment, it is important to prevent and reduce the severity of lymphedema. The purpose of this study is to evaluate whether preoperative exercise is effective in preventing lymphedema after surgery. For secondary outcome, the preventive effects of exercise on other upper extremity dysfunctions (eg. pectoralis tightness, Axillary web syndrome, Adhesive capsulitis), which are common in breast cancer patients, were assessed.

Conditions

  • Breast Neoplasms

Interventions

BEHAVIORAL

Aerobic exercise, Strength training, Flexibility exercise

Aerobic exercise: 30-40 minutes/time, 3-5 times a week, intensity of 4-6 points on the Rating of Perceived Exertion(RPE) 10-point scale(A simple conversation is possible during exercise, but the intensity is such that you feel out of breath) Strength training: 2-3 times a week, 3 sets of 10 repetitions per movement * Upper extremities: Biceps brachii, triceps brachii, deltoid, pectoralis muscle exercise * Lower extremities: gluteus maximus, hamstrings, quadriceps exercise Flexibility exercise: Stretching and mobility exercises reflecting post-surgery rehabilitation

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Jaeyong Jeon · Asan Medical Center

  • Heejeong Kim · Asan Medical Center

  • Seungwoo Cha · Asan Medical Center

  • Chul Jung · Asan Medical Center

  • Hwayeong Cheon · Asan Medical Center

  • Junghwa Do · Asan Medical Center

  • Woojin Jeong · Asan Medical Center

  • Doyoung Kim · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2025-10-30
Completion
2025-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06421285 on ClinicalTrials.gov